Clinical Trials Sponsored by Kathryn Stephenson

Total 89 results

Stephenson Eye Associates

Recruiting

A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray (TSUNAMI)

Dry Eye Disease

United States
Kathryn O'Connor

Completed

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression (MAOI)

Treatment Resistant Depression

United States
Kathryn Richdale

Completed

Toric Contact Lens Digital Performance and Comfort Study

Astigmatism

United States
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
Kathryn Stephenson
National Institute of Allergy and Infectious Diseases (NIAID); Walter Reed...

Completed

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study (Z001)

Zika

United States
University of Oklahoma
Stephenson Cancer Center

Completed

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Breast Neoplasms

United States
Kathryn Gold
Pfizer

Active, not recruiting

Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

United States
Kathryn Beardsall

Completed

Point of Care Ketone Measurement in the Newborn (POCKET)

Hypoglycaemia

United Kingdom
Callum Stephenson
Online PsychoTherapy Clinic

Completed

Using Online Delivered Therapy and Brain Imaging to Better Understand OCD

Obsessive-Compulsive Disorder

Canada
St. Stephens Clinical Research

Completed

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP (RIFT)

HIV

United Kingdom
St. Stephens Clinical Research

Unknown

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers (RADIO)

Tuberculosis | HIV-1-infection
St Stephens Aids Trust

Unknown

Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

HIV

United Kingdom
St Stephens Aids Trust

Completed

A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine

HIV

United Kingdom
St Stephens Aids Trust

Completed

The Pharmacology/Aging Clinic (SSAT041)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

HIV

United Kingdom
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Men Who Have Sex With Men (MSM) Neurocog 1&2 Study (MSM Neurocog)

HIV Related Neurocognitive Impairment

United Kingdom
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers

HIV

United Kingdom
St Stephens Aids Trust

Completed

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (SSAT033)

HIV Infection

United Kingdom
St Stephens Aids Trust

Terminated

Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Raltegravir and Ezetimibe PK Study

HIV

United Kingdom
St Stephens Aids Trust

Completed

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

HIV

United Kingdom
St Stephens Aids Trust

Completed

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

HIV

Germany, Spain, France, United Kingdom, Belgium, Italy
St Stephens Aids Trust

Completed

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT) (CHAT)

HIV

United Kingdom
St Stephens Aids Trust

Completed

A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study (CINAMMON)

HIV

United Kingdom
St Stephens Aids Trust

Completed

A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers

HIV

United Kingdom
St Stephens Aids Trust

Completed

The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function (SSAT044)

HIV

United Kingdom
St Stephens Aids Trust

Withdrawn

Depot Contraception With and Without Lopinavir/Ritonavir

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Raltegravir Insulin Sensitivity Study

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125

HIV

United Kingdom
St Stephens Aids Trust

Unknown

SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease

United Kingdom
St Stephens Aids Trust

Unknown

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma (SSAT042)

Lymphoma | HIV

United Kingdom
St Stephens Aids Trust

Completed

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study (SSAT043)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers

HIV Infections | HIV Infection

United Kingdom
St Stephens Aids Trust

Terminated

NNRTI/PI Toxicity Switch to Darunavir Study

HIV

United Kingdom
St Stephens Aids Trust

Completed

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

HIV Infections | HIV

United Kingdom
St Stephens Aids Trust

Completed

Double Protease Inhibitor to Darunavir Switch Study

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers

HIV Infections

United Kingdom
St Stephens Aids Trust

Terminated

Pre-Exposure Prophylaxis Using TMC278LA

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

TMC 125 Blood Levels Study

HIV Infections

United Kingdom
Anne Kathrine Staehr-Rye

Recruiting

Ambulatory Versus Inpatient Initiation of Home Mechanical Ventilation

Amyotrophic Lateral Sclerosis

Denmark
Ryan Stephenson

Recruiting

Naltrexone and Propranolol Combined With Immunotherapy

Advanced Melanoma

United States
Kathryn Wagner
Pfizer

Completed

A Trial of PF-06252616 in Ambulatory Participants With LGMD2I

LGMD2I

United States
Prof Kathryn Maitland
Imperial College London

Completed

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia (Tx30)

Severe Anaemia

Uganda
Katelyn Atkins

Not yet recruiting

Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

Oligometastatic Disease

United States
Kathy Miller

Completed

Impact of LOFT Therapy™ on Breast Cancer Survivors

Breast Neoplasms

United States
Kathy Miller

Terminated

Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis

Bone Cancer | Metastasis

United States

3

Subscribe